LeMaitre Vascular Management
Management criteria checks 2/4
LeMaitre Vascular's CEO is George LeMaitre, appointed in Jun 1992, has a tenure of 32.92 years. total yearly compensation is $3.24M, comprised of 19.2% salary and 80.8% bonuses, including company stock and options. directly owns 8.09% of the company’s shares, worth €127.25M. The average tenure of the management team and the board of directors is 8.8 years and 22.3 years respectively.
Key information
George LeMaitre
Chief executive officer
US$3.2m
Total compensation
| CEO salary percentage | 19.23% |
| CEO tenure | 32.9yrs |
| CEO ownership | 8.1% |
| Management average tenure | 8.8yrs |
| Board average tenure | 22.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | US$45m |
| Dec 31 2024 | US$3m | US$622k | US$44m |
| Sep 30 2024 | n/a | n/a | US$41m |
| Jun 30 2024 | n/a | n/a | US$38m |
| Mar 31 2024 | n/a | n/a | US$34m |
| Dec 31 2023 | US$2m | US$593k | US$30m |
| Sep 30 2023 | n/a | n/a | US$27m |
| Jun 30 2023 | n/a | n/a | US$25m |
| Mar 31 2023 | n/a | n/a | US$21m |
| Dec 31 2022 | US$2m | US$568k | US$21m |
| Sep 30 2022 | n/a | n/a | US$21m |
| Jun 30 2022 | n/a | n/a | US$22m |
| Mar 31 2022 | n/a | n/a | US$27m |
| Dec 31 2021 | US$2m | US$473k | US$27m |
| Sep 30 2021 | n/a | n/a | US$28m |
| Jun 30 2021 | n/a | n/a | US$29m |
| Mar 31 2021 | n/a | n/a | US$24m |
| Dec 31 2020 | US$1m | US$311k | US$21m |
| Sep 30 2020 | n/a | n/a | US$19m |
| Jun 30 2020 | n/a | n/a | US$16m |
| Mar 31 2020 | n/a | n/a | US$18m |
| Dec 31 2019 | US$1m | US$438k | US$18m |
| Sep 30 2019 | n/a | n/a | US$19m |
| Jun 30 2019 | n/a | n/a | US$18m |
| Mar 31 2019 | n/a | n/a | US$23m |
| Dec 31 2018 | US$1m | US$438k | US$23m |
Compensation vs Market: George's total compensation ($USD3.24M) is above average for companies of similar size in the German market ($USD1.77M).
Compensation vs Earnings: George's compensation has increased by more than 20% in the past year.
CEO
George LeMaitre (59 yo)
Mr. George W. LeMaitre has been Chief Executive Officer of Lemaitre Vascular, Inc. since June 1992 and has been its Chairman since 2004. Mr. LeMaitre served as the President of Lemaitre Vascular from June...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 32.9yrs | US$3.24m | 8.09% € 127.2m | |
| President & Director | 17.8yrs | US$1.15m | 0.080% € 1.3m | |
| Senior Vice President of Operations | 20.3yrs | US$869.70k | 0.017% € 261.4k | |
| Founder and Chairman of Scientific Advisory Board | 42.3yrs | US$138.40k | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Vice President of Marketing | 22.3yrs | no data | no data | |
| Senior Director of Human Resources | 5.3yrs | no data | no data | |
| Senior Vice President of Information Technology | 1yr | no data | no data | |
| Senior Vice President of Sales – Central Europe | 1.1yrs | no data | no data | |
| Senior Vice President of Advanced Manufacturing Engineering | 2.3yrs | no data | no data | |
| Senior Vice President of Clinical | 12.3yrs | no data | no data | |
| Senior Vice President of EMEA Operations | 4.6yrs | no data | no data |
Experienced Management: LHU's management team is seasoned and experienced (8.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 32.9yrs | US$3.24m | 8.09% € 127.2m | |
| President & Director | 24yrs | US$1.15m | 0.080% € 1.3m | |
| Founder and Chairman of Scientific Advisory Board | no data | US$138.40k | no data | |
| Independent Director | 22.3yrs | US$154.00k | 0.025% € 400.3k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 16.7yrs | US$162.00k | 0.25% € 4.0m | |
| Independent Director | 5.1yrs | US$144.50k | 0.013% € 203.2k |
Experienced Board: LHU's board of directors are seasoned and experienced ( 22.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 23:21 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LeMaitre Vascular, Inc. is covered by 20 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Raymond Myers | Benchmark Company |
| Jan Wald | Benchmark Company |